[Hallervorden-Spatz disease and botulinum toxin].
Riol Diego
M
M
Narbona García
J
J
D000818:Animals; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005260:Female; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D006211:Pantothenate Kinase-Associated Neurodegeneration / Q000188:drug therapy*; D051381:Rats
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A
Enfermedad de Hallervorden-Spatz y toxina botulínica.